Business

Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction

Uptake of Biogen's breakthrough Alzheimer's drug, Leqembi, appears to be picking up, with roughly $40 million in sales for the quarter.

adminadmin
Aug 1, 2024 - 19:00
 0  5
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
Uptake of Biogen's breakthrough Alzheimer's drug, Leqembi, appears to be picking up, with roughly $40 million in sales for the quarter.
Read More

Tags:

Previous Article

UL Solutions CEO Jennifer Scanlon goes one-on-one with Jim Cramer

Next Article

Wayfair CEO likens home goods slowdown to 2008 financial crisis: 'Customers rema...

admin
admin

Related Posts

Stocks making the biggest premarket moves: Oracle, Paramount, Birkenstock, Rentokil Initial and more

Stocks making the biggest premarket moves: Oracle, Para...

admin Jun 12, 2024  0  4

Healthy Returns: What we know about the next round of Covid vaccines

Healthy Returns: What we know about the next round of C...

admin Jun 13, 2024  0  9

GameStop closes more than 12% lower after annual meeting fails to offer details on firm's strategy

GameStop closes more than 12% lower after annual meetin...

admin Jun 18, 2024  0  5